RATIONALE: The common cold virus, human rhinovirus (HRV), is the most frequent cause of asthma exacerbations. However, a possible contribution of HRV to the pathogenesis of chronic, persistent asthma has not been defined. OBJECTIVES: To determine if patients with stable asthma, who are free of clinical signs of a respiratory infection for at least 3 weeks, harbor HRV in their bronchi more frequently than nonasthmatic control subjects, and whether clinical features of asthma are associated with the presence of HRV. METHODS: Immunohistochemistry and the indirect in situ reverse transcription-polymerase chain reaction method were used to detect the presence of HRV in bronchial mucosal biopsies in patients with asthma and nonasthmatic control subjects. MEASUREMENTS AND MAIN RESULTS: HRV was found by immunohistochemistry in 9 of 14 bronchial biopsies from subjects with asthma (64.3%) and 2 of 6 nonasthmatic control subjects (33.3%) (P = 0.38). With the more sensitive indirect in situ reverse transcription-polymerase chain reaction method, HRV was found in the mucosal biopsies of 73% of patients with asthma and 22% of nonasthmatic control subjects (P < 0.001). Subjects positive for HRV had lower pulmonary function, higher numbers of blood eosinophils and leukocytes, and eosinophilic infiltration in bronchial mucosa. CONCLUSIONS: HRV was detected in the lower airway tissue of patients with asthma significantly more often than in nonasthmatic subjects, and its presence was associated with clinical features of more severe disease.
RATIONALE: The common cold virus, human rhinovirus (HRV), is the most frequent cause of asthma exacerbations. However, a possible contribution of HRV to the pathogenesis of chronic, persistent asthma has not been defined. OBJECTIVES: To determine if patients with stable asthma, who are free of clinical signs of a respiratory infection for at least 3 weeks, harbor HRV in their bronchi more frequently than nonasthmatic control subjects, and whether clinical features of asthma are associated with the presence of HRV. METHODS: Immunohistochemistry and the indirect in situ reverse transcription-polymerase chain reaction method were used to detect the presence of HRV in bronchial mucosal biopsies in patients with asthma and nonasthmatic control subjects. MEASUREMENTS AND MAIN RESULTS:HRV was found by immunohistochemistry in 9 of 14 bronchial biopsies from subjects with asthma (64.3%) and 2 of 6 nonasthmatic control subjects (33.3%) (P = 0.38). With the more sensitive indirect in situ reverse transcription-polymerase chain reaction method, HRV was found in the mucosal biopsies of 73% of patients with asthma and 22% of nonasthmatic control subjects (P < 0.001). Subjects positive for HRV had lower pulmonary function, higher numbers of blood eosinophils and leukocytes, and eosinophilic infiltration in bronchial mucosa. CONCLUSIONS:HRV was detected in the lower airway tissue of patients with asthma significantly more often than in nonasthmatic subjects, and its presence was associated with clinical features of more severe disease.
Authors: Anne G Mosser; Rebecca Brockman-Schneider; Svetlana Amineva; Lacinda Burchell; Julie B Sedgwick; William W Busse; James E Gern Journal: J Infect Dis Date: 2002-02-19 Impact factor: 5.226
Authors: E Furukawa; T Ohrui; M Yamaya; T Suzuki; H Nakasato; T Sasaki; A Kanda; H Yasuda; H Nishimura; H Sasaki Journal: Clin Exp Allergy Date: 2004-05 Impact factor: 5.018
Authors: Anne Pitkäranta; Tuomo Puhakka; Mika J Mäkelä; Olli Ruuskanen; Olli Carpen; Antti Vaheri Journal: J Med Virol Date: 2003-06 Impact factor: 2.327
Authors: Amy S Feldman; Yuan He; Martin L Moore; Marc B Hershenson; Tina V Hartert Journal: Am J Respir Crit Care Med Date: 2015-01-01 Impact factor: 21.405
Authors: Ellen F Foxman; James A Storer; Megan E Fitzgerald; Bethany R Wasik; Lin Hou; Hongyu Zhao; Paul E Turner; Anna Marie Pyle; Akiko Iwasaki Journal: Proc Natl Acad Sci U S A Date: 2015-01-05 Impact factor: 11.205
Authors: Kaharu C Sumino; Michael J Walter; Cassandra L Mikols; Samantha A Thompson; Monique Gaudreault-Keener; Max Q Arens; Eugene Agapov; David Hormozdi; Anne M Gaynor; Michael J Holtzman; Gregory A Storch Journal: Thorax Date: 2010-07 Impact factor: 9.139
Authors: Amit K Mehta; Wei Duan; Astrid M Doerner; Suzanne L Traves; David H Broide; David Proud; Bruce L Zuraw; Michael Croft Journal: J Allergy Clin Immunol Date: 2015-06-19 Impact factor: 10.793
Authors: Ilona Jaspers; Patricia A Sheridan; Wenli Zhang; Luisa E Brighton; Kelly D Chason; Xiaoyang Hua; Stephen L Tilley Journal: Part Fibre Toxicol Date: 2009-08-14 Impact factor: 9.400